Open | $12.660 |
Close | $12.210 |
Volume / Avg. | 174.687K / 132.839K |
Day Range | 11.920 - 12.660 |
52 Wk Range | 6.920 - 16.645 |
Market Cap | $221.642M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 4.45% |
Days to Cover | 8.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of OptimizeRx (NASDAQ: OPRX) through any online brokerage.
Other companies in OptimizeRx’s space includes: MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), Trxade Health (NASDAQ:MEDS), Definitive Healthcare (NASDAQ:DH) and TruBridge (NASDAQ:TBRG).
The latest price target for OptimizeRx (NASDAQ: OPRX) was reported by RBC Capital on Wednesday, January 10, 2024. The analyst firm set a price target for 17.00 expecting OPRX to rise to within 12 months (a possible 39.23% upside). 7 analyst firms have reported ratings in the last year.
The stock price for OptimizeRx (NASDAQ: OPRX) is $12.21 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for OptimizeRx.
OptimizeRx’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for OptimizeRx.
OptimizeRx is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.